Lyra Health, a leader in Workforce Mental Health solutions for employers, today shared early insights from its 2025 Workforce Mental Health Trends Forecast. The fifth annual study found that 81% of benefits leaders are increasingly worried about the rising levels…
Repare Therapeutics Inc. (Nasdaq: RPTX), a clinical-stage precision oncology company, today announced positive data from its MYTHIC Phase 1 gynecologic expansion clinical trial. The trial evaluated the combination of lunresertib and camonsertib (Lunre+Camo) at the recommended Phase 2 dose (RP2D)…
NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company specializing in surface acoustic wave (SAW) technology, has announced the renewal of its exclusive distribution agreement with Ultra Pain Products, Inc. (UPPI) for the distribution of the PainShield device. The five-year extension…
SamanTree Medical, a leader in oncologic surgical imaging innovation, announced promising results from the SHIELD study, to be presented at the 2024 San Antonio Breast Cancer Symposium (SABCS) on Dec. 12. The findings reveal that the Histolog® Scanner, a confocal…
NeoGenomics, Inc. (NASDAQ: NEO), a leader in oncology testing services, has announced the publication of a new study in ESMO Open. The study highlights the potential of circulating tumor DNA (ctDNA) as a tool for monitoring molecular residual disease (MRD)…
Syncell, a leader in advanced subcellular protein purification and spatial proteomics analysis, has successfully closed a $15 million Series A funding round, bringing its total funding to $30 million. The capital will be used to drive the global commercialization and…
Mindset Medical, Inc., a digital health company, today announced that it has received FDA 510(k) clearance for its contactless pulse rate measurement device, the Informed Vital Core (IVC) App. This marks the company’s first FDA clearance and is a major…
RevBio, Inc. announced that it has received FDA approval to expand its ongoing clinical trial to use TETRANITE®, its bone adhesive biomaterial, for immediate cranial flap fixation. Additionally, the company has secured reimbursement coverage from the Centers for Medicare and…
Protaryx Medical, a leader in medical device innovation, is proud to announce the successful completion of its First-in-Human (FIH) study for its groundbreaking transseptal puncture technology. The study, conducted on December 3, 2024, at Sanatorio Italiano de Asunción in Paraguay,…
Alpha Cognition Inc. (Nasdaq: ACOG) (CSE: ACOG), a biopharmaceutical company focused on developing innovative therapies for neurodegenerative disorders, today announced promising interim preclinical data supporting the ongoing development of ALPHA-1062 for the treatment of mild traumatic brain injury (mTBI). The…
The Menarini Group, a global leader in pharmaceuticals and diagnostics, and its subsidiary Stemline Therapeutics, focused on delivering innovative oncology treatments, have partnered with MEDSIR, a top independent clinical research organization in oncology and part of Oncoclínicas & Co., the…
Sol-Millennium® Medical Group, a leading medical device manufacturer, has introduced an innovative needle-free insulin injection device that has garnered widespread acclaim in Canada. This groundbreaking technology aims to enhance the lives of millions of people with diabetes by eliminating the…